TIR expectations

I had to laugh recently. Various advertising from diabetes companies comes through my feeds, and this time it was an ad from Medtronic Australia, touting the improvements in TIR (Time In Range) for their 670G pump. Here it is reproduced in its entirety:   I’m not sure exactly where they sourced this data, but presumably …

TIR expectations Read More »

Accu-Chek Solo – wearing a dummy

At last week’s diabetes congress in Sydney, Accu-Chek announced that the tubeless Solo pump will be available in November once the government’s Prostheses List is next updated. The Prostheses List controls which pumps are available through private health insurance, and is only updated several times a year. I mentioned this in the ADC 2019 – Day …

Accu-Chek Solo – wearing a dummy Read More »

Cheaper CGM!

At the 2019 Australasian Diabetes Congress (last week) no announcements were made about Dexcom G6. It’s still waiting for approval from the TGA before AMSL will be able to start selling or even marketing it. The strongest story I heard was just “hopefully before the end of 2019”. But in the last few days some …

Cheaper CGM! Read More »

ADC 2019 – Day 2

Day 2 of the Australasian Diabetes Congress didn’t have many new technology announcements, but it did involve lots more presentations. Many more than I was able to attend. I’ve already reported on the Ypsomed announcement of new infusion set options. The other highlights for me included: A masterclass on some of the issues with including …

ADC 2019 – Day 2 Read More »